We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. “In this final follow-up from the SIMPLICITY HTN-3 trial ...

Please provide your email address to receive an email when new articles are posted on . Radiofrequency renal denervation is estimated to be a cost-effective treatment for uncontrolled hypertension.

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...

Medtronic and Recor Medical stand to benefit from national Medicare coverage for their new device-based treatments for patients with uncontrolled high blood pressure. Medtronic and Recor have had ...

National coverage analysis is the first-of-its kind for a minimally invasive, interventional treatment for high blood pressure Milestone is supported by large public health need and robust, long-term ...

Renal denervation using radiofrequency energy is a cost-effective and high-value intervention for the treatment of uncontrolled hypertension from the perspective of the US healthcare system, an ...

Kidney denervation, a procedure where the nerves in renal arteries are burned, may be a future treatment for people whose blood pressure remains high despite medication use. Results from the ...

Renal denervation delivers radiofrequency energy to overactive nerves in renal arteries and branch vessels. Renal denervation along with use of antihypertensive drugs leads to a sustained reduction in ...

BOROUGH PARK — AN INNOVATIVE PROCEDURE TO CALM THE NERVOUS SYSTEM AND KIDNEYS was launched at Maimonides Medical Center this week. Maimonides has become the first hospital in Brooklyn to offer the ...

Cardiologists are welcoming the arrival of a new device-based hypertension treatment called renal denervation and asking Medicare to cover the procedure for a large patient population. Doctors, ...

Equity/Stock(s)/Options - Biostar Ventures Grant Support/Research Contract - Medtronic; Teleflex; Biotronik; CSI Consultant Fee/Honoraria/Speaker's Bureau - CSI; Medtronic Receive the the latest news, ...

HANGZHOU, China, July 10, 2023 /PRNewswire/ -- Broncus Holding Corporation (HKG:2216) has completed the first case of registered clinical trials of its targeted lung denervation (''TLD'') ...